Stay updated on AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The record now presents details of the completed Phase 3 STRIDE-1 study of AXS-05 versus bupropion for treatment-resistant major depressive disorder, including its eligibility criteria, study locations, and measured outcomes.
    Difference
    62%
    Check dated 2026-11-08T13:48:17.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:09:48.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the ClinicalTrials.gov 403 error page.
    Difference
    1%
    Check dated 2026-10-25T14:02:06.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page displays the ClinicalTrials.gov record for the completed STRIDE-1 study of AXS-05 for treatment-resistant major depressive disorder, including its design, eligibility criteria, and outcomes.
    Difference
    63%
    Check dated 2026-10-18T14:12:31.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:11:00.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The 403 error state is removed, and the page now presents the actual study details for NCT02741791. This reflects the page transitioning from an error to a usable study record.
    Difference
    0.5%
    Check dated 2026-09-27T19:51:10.000Z thumbnail image

Stay in the know with updates to AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial page.